Genexa
PrivateLast Round
Series A
Jul 14, 2021
Est. Valuation
$200M
Total Funding Raised
$60.5M
Company Overview
Genexa is a pharmaceutical company that develops and markets clean over-the-counter medicines using effective active ingredients without artificial inactive ingredients.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Home & Lifestyle
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genexa Comparables
Compare Genexa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KinderFarms | 82% | |
| EEZ Co. | 81% | |
| Hyland's Naturals | 79% |
Genexa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 14, 2021 | ||||
| Growth Equity | Nov 20, 2018 | ||||
| Convertible Debt | Nov 20, 2018 |
Genexa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Platinum Mile Ventures | Series A |
| Verlinvest | Series A |
| North Castle Partners | Series A |
| Monogram Capital Partners | Series A |
| Point King Capital | Series A |
| Unilever Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2021
$60M round led by Monogram Capital Partners.
Recent news
Latest coverage and updates
- partners_withSep 15, 2026
Genexa Inc. partnered with Good Inside on Sep 15th '26.
Genexa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genexa's valuation, stock price, and market status.
Is Genexa a public or private company?
Genexa is a private company.
What is the current stock price of Genexa?
Genexa is a private company with no public stock price. No recent secondary market data is available.
How much is Genexa worth (valuation)?
Genexa's valuation is estimated at $200.0M based on funding round data.
Can I buy Genexa stock?
Genexa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genexa's last funding round?
Genexa's most recent funding round was Series A on July 14, 2021.
Who are the main investors in Genexa?
Key investors in Genexa include Monogram Capital Partners.
Will Genexa IPO soon?
No public IPO plans have been announced for Genexa.
How can I track Genexa secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genexa's secondary market activity and sign up for updates.